Cardiology Research

Cardiac Regeneration & Stem Cell Therapies

Cardiac regeneration has emerged as a transformative approach to repairing damaged heart tissue. Stem cell therapies, including mesenchymal, induced pluripotent, and cardiac progenitor cells, offer significant potential for restoring myocardial function post-infarction. Research focuses on optimizing delivery methods, improving cell survival, and enhancing tissue integration. Preclinical and clinical studies have demonstrated promising outcomes, including improved ejection fraction and reduced fibrosis. Advances in scaffold-based tissue engineering and biocompatible matrices further enhance regenerative outcomes. Combining stem cells with growth factors, exosomes, and gene-editing tools is opening new horizons in myocardial repair. Ethical, safety, and regulatory considerations are crucial for clinical translation. Ongoing innovation in this field aims to develop standardized protocols, minimize immune rejection, and integrate regenerative therapies with conventional cardiac care. The session emphasizes the latest clinical trials, mechanistic insights, and translational strategies that could revolutionize heart failure treatment, offering long-term functional improvement and significantly reducing morbidity in cardiovascular disease patients.